Bivalirudin Infusion for Ventricular Infarction Limitation
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2018
Price : $35 *
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms BIVAL
- Sponsors The Medicines Company
- 31 Aug 2018 Biomarkers information updated
- 21 Jul 2016 The trial was completed in Netherlands.
- 20 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.